Page last updated: 2024-09-03

omega-n-methylarginine and Carcinoma, Renal Cell

omega-n-methylarginine has been researched along with Carcinoma, Renal Cell in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kondapaneni, M; Laubach, VE; McGregor, JR; Salvemini, D; Samlowski, WE; Tharkar, S	1
Ewer, M; Fonseca, GA; Griffith, OW; Jones, E; Kilbourn, RG; Logothetis, CJ; Price, K; Striegel, A	1
Adolfsson, J; Bergerheim, US; Brundin, L; Jansson, OT; Morcos, E; Wiklund, NP	1
Fonseca, GA; Griffith, OW; Kilbourn, RG; Trissel, LA	1

Trials

2 trial(s) available for omega-n-methylarginine and Carcinoma, Renal Cell

Article	Year
NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension. Critical care medicine, 1995, Volume: 23, Issue:6 Topics: Adult; Arginine; Carcinoma, Renal Cell; Drug Administration Schedule; Female; Hemodynamics; Humans; Hypotension; Interleukin-2; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Pilot Projects; Prospective Studies	1995
Strategies to reduce side effects of interleukin-2: evaluation of the antihypotensive agent NG-monomethyl-L-arginine. The cancer journal from Scientific American, 2000, Volume: 6 Suppl 1 Topics: Adult; Carcinoma, Renal Cell; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Hypotension; Interleukin-2; Kidney Neoplasms; Killer Cells, Lymphokine-Activated; Male; Middle Aged; Nitrates; omega-N-Methylarginine	2000

Article

Year

NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension.

Critical care medicine, 1995, Volume: 23, Issue:6

Topics: Adult; Arginine; Carcinoma, Renal Cell; Drug Administration Schedule; Female; Hemodynamics; Humans; Hypotension; Interleukin-2; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Pilot Projects; Prospective Studies

1995

Strategies to reduce side effects of interleukin-2: evaluation of the antihypotensive agent NG-monomethyl-L-arginine.

The cancer journal from Scientific American, 2000, Volume: 6 Suppl 1

Topics: Adult; Carcinoma, Renal Cell; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Hypotension; Interleukin-2; Kidney Neoplasms; Killer Cells, Lymphokine-Activated; Male; Middle Aged; Nitrates; omega-N-Methylarginine

2000

Other Studies

2 other study(ies) available for omega-n-methylarginine and Carcinoma, Renal Cell

Article	Year
Endothelial nitric oxide synthase is a key mediator of interleukin-2-induced hypotension and vascular leak syndrome. Journal of immunotherapy (Hagerstown, Md. : 1997), 2011, Volume: 34, Issue:5 Topics: Animals; Blood Pressure; Capillary Leak Syndrome; Carcinoma, Renal Cell; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Humans; Hypotension; Interleukin-2; Manganese; Melanoma; Methylene Blue; Mice; Mice, Inbred Strains; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Organometallic Compounds; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Soluble Guanylyl Cyclase; Superoxides	2011
Nitric oxide synthase activity in human renal cell carcinoma. The Journal of urology, 1998, Volume: 160, Issue:2 Topics: Analysis of Variance; Anticarcinogenic Agents; Arginine; Calcium; Carcinogens; Carcinoma, Renal Cell; Cell Division; Cells, Cultured; Citrulline; DNA; Enzyme Inhibitors; Humans; Interleukin-2; Kidney Neoplasms; Kidney Tubules, Proximal; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Penicillamine; Thymidine; Tumor Cells, Cultured	1998

Article

Year

Endothelial nitric oxide synthase is a key mediator of interleukin-2-induced hypotension and vascular leak syndrome.

Journal of immunotherapy (Hagerstown, Md. : 1997), 2011, Volume: 34, Issue:5

Topics: Animals; Blood Pressure; Capillary Leak Syndrome; Carcinoma, Renal Cell; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Humans; Hypotension; Interleukin-2; Manganese; Melanoma; Methylene Blue; Mice; Mice, Inbred Strains; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Organometallic Compounds; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Soluble Guanylyl Cyclase; Superoxides

2011

Nitric oxide synthase activity in human renal cell carcinoma.

The Journal of urology, 1998, Volume: 160, Issue:2

Topics: Analysis of Variance; Anticarcinogenic Agents; Arginine; Calcium; Carcinogens; Carcinoma, Renal Cell; Cell Division; Cells, Cultured; Citrulline; DNA; Enzyme Inhibitors; Humans; Interleukin-2; Kidney Neoplasms; Kidney Tubules, Proximal; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Penicillamine; Thymidine; Tumor Cells, Cultured

1998